Delta-Fly Pharma, Inc. Logo

Delta-Fly Pharma, Inc.

Develops innovative, gentle anticancer agents with reduced side effects for cancer patients.

4598 | T

Overview

Corporate Details

ISIN(s):
JP3549370009
LEI:
Country:
Japan
Address:
徳島市川内町宮島錦野37番地の5
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Delta-Fly Pharma, Inc. is a biopharmaceutical company specializing in the research and development of anticancer agents. The company utilizes its proprietary "Module Drug Development" concept to create innovative and "gentle" cancer treatments designed to have reduced side effects and be available at a reasonable price. Its development pipeline focuses on small molecule and RNA therapeutics for various cancers, including Acute Myeloid Leukemia. Delta-Fly Pharma's mission is to develop medicines that benefit cancer patients and society through its unique drug discovery approach.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-14 07:39
Interim Report
確認書
Japanese 8.9 KB
2025-11-14 07:35
Interim Report
半期報告書-第16期(2025/04/01-2026/03/31)
Japanese 206.9 KB
2025-06-27 08:44
Post-Annual General Meeting Information
臨時報告書
Japanese 24.4 KB
2025-06-27 08:39
Governance Information
内部統制報告書-第15期(2024/04/01-2025/03/31)
Japanese 23.0 KB
2025-06-27 08:34
Registration Form
確認書
Japanese 8.8 KB
2025-06-27 08:30
Registration Form
有価証券報告書-第15期(2024/04/01-2025/03/31)
Japanese 1.1 MB
2025-04-14 08:30
Prospectus
有価証券届出書(組込方式)
Japanese 289.0 KB
2024-11-14 07:39
Interim Report
確認書
Japanese 8.9 KB
2024-11-14 07:36
Interim Report
半期報告書-第15期(2024/04/01-2025/03/31)
Japanese 180.2 KB
2024-10-07 08:00
Major Shareholding Notification
臨時報告書
Japanese 22.6 KB
2024-09-20 08:00
Registration Form
有価証券届出書(組込方式)
Japanese 326.2 KB
2024-09-11 08:00
Major Shareholding Notification
臨時報告書
Japanese 22.8 KB
2024-06-28 08:31
Post-Annual General Meeting Information
臨時報告書
Japanese 23.5 KB
2024-06-28 08:28
Registration Form
確認書
Japanese 8.8 KB
2024-06-28 08:25
Governance Information
内部統制報告書-第14期(2023/04/01-2024/03/31)
Japanese 22.6 KB

Automate Your Workflow. Get a real-time feed of all Delta-Fly Pharma, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Delta-Fly Pharma, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Delta-Fly Pharma, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Neonode Inc. Logo
Licenses optical sensing and computer vision for HMI in automotive and consumer electronics.
United States of America
NEON
Neovacs Logo
Develops immunotherapy vaccines for autoimmune diseases & invests in BioTech/MedTech companies.
France
ALNEV
Mineral explorer of rare earths, niobium, uranium, and copper assets in Australia and Zambia.
Australia
NFM
NexGen Energy Ltd. Logo
Uranium exploration company developing a high-grade mine to supply global clean energy fuel.
United States of America
NXE
Nexxen International Ltd. Logo
End-to-end programmatic ad platform for advertisers, agencies, & publishers, specializing in video & CTV.
United States of America
NEXN
NFL Biosciences Logo
Develops botanical drug candidates to treat smoking and alcohol addictions.
France
ALNFL
NGS Group Logo
Nordic staffing & recruitment for healthcare, education, and social services sectors.
Sweden
NGS
Nihon M&A Center Holdings Inc. Logo
M&A advisory firm specializing in brokerage and consulting for Japanese SMEs, including cross-border deals.
Japan
2127
Noile-Immune Biotech Inc. Logo
Developing PRIME technology-enhanced CAR-T cell immunotherapies for treating solid tumors.
Japan
4893
NRGene Technologies Ltd. Logo
AI-powered genomic analysis software to accelerate and optimize plant and animal breeding.
Israel
NRGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.